Stocks › CTMX
CytomX CTMX
US equityMarket cap rank #3644
$2.03 −$0.02 (-0.98%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $2.04 +0.65%
Open$2.02
Prev close$2.05
Day range$1.97 – $2.16
Volume4.87M
Market cap$442.55M
P/E (TTM)–
Dividend yield–
CTMX Stock News
Headlines matching CytomX or the CTMX ticker, most recent first.
- Piper Sandler Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $12
- Barclays Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $16
- J.P. Morgan Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $11
- J.P. Morgan Maintains CytomX(CTMX.US) With Buy Rating, Cuts Target Price to $11 Negative
- Wedbush Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $11
- A Quick Look at Today's Ratings for CytomX(CTMX.US), With a Forecast Between $11 to $16
- Guggenheim Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $15
- Wolfe Research Initiates CytomX(CTMX.US) With Buy Rating, Announces Target Price $6
- Oppenheimer Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $12
- H.C. Wainwright Maintains CytomX(CTMX.US) With Buy Rating, Cuts Target Price to $11 Negative
- Cantor Fitzgerald Maintains CytomX(CTMX.US) With Buy Rating, Raises Target Price to $10 Positive
- Guggenheim Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $10
- Piper Sandler Maintains CytomX(CTMX.US) With Buy Rating, Raises Target Price to $12 Positive
- Barclays Maintains CytomX(CTMX.US) With Buy Rating, Raises Target Price to $16 Positive
- Guggenheim Maintains CytomX(CTMX.US) With Buy Rating, Raises Target Price to $15 Positive
No comments yet — be the first to weigh in on CTMX.
Sign in to join the discussion.